Biogen Inc logo

Biogen Inc

BUE:BIIB (USA)  
ARS 7993.50 (-0.53%) Mar 23
P/E:
12.90
P/B:
2.90
Market Cap:
ARS 7.87T ($ 38.34B)
Enterprise V:
ARS 8.22T ($ 40.06B)
Volume:
24.00
Avg Vol (2M):
149.00
Also Trade In:
Volume:
24.00
Market Cap ARS:
7.87T
Market Cap $:
38.34B
PE Ratio:
12.90
Avg Vol (2M):
149.00
Enterprise Value ARS:
8.22T
Enterprise Value $:
40.06B
PB Ratio:
2.90
Market Cap ARS M 7,868,661.49
Enterprise Value ARS M 8,222,156.35
P/E(ttm) 12.90
PE Ratio without NRI 12.90
Forward PE Ratio 17.51
Price/Book 2.90
Price/Sales 3.88
Price/Free Cash Flow 34.50
Price/Owner Earnings 19.36
Payout Ratio % --
Revenue (TTM) ARS M 1,358,448.00
EPS (TTM) ARS 2,817.14
Beneish M-Score -2.22
10-y EBITDA Growth Rate % 10.10
5-y EBITDA Growth Rate % -5.30
y-y EBITDA Growth Rate % 55.00
EV-to-EBIT 10.61
EV-to-EBITDA 9.23
PEG --
Shares Outstanding M 144.49
Net Margin (%) 29.95
Operating Margin % 28.52
Pre-tax Margin (%) 35.31
Quick Ratio 2.58
Current Ratio 2.99
ROA % (ttm) 12.49
ROE % (ttm) 25.31
ROIC % (ttm) 14.19
Dividend Yield % --
Altman Z-Score 4.28
Piotroski F-Score 6.00
Positive ROA Y
Positive CFROA Y
Higher ROA y-y Y
Cash flow > Earnings N
Lower Leverage y-y Y
Higher Current Ratio y-y Y
Less Shares Outstanding y-y Y
Gross Margin Increase y-y N
Higher Asset Turnover y-y N

BUE:BIIB Number of Guru Trades

To

BUE:BIIB Volume of Guru Trades

To

Gurus Latest Trades with BUE:BIIB

BUE:BIIB is held by these investors

No Available Data